Charming Medical Ltd (MCTA)
↓ Download CSVIn fiscal 2026, Charming Medical Ltd reported revenue of $4.81M, down 22.7% from the prior year. The company ran a net loss, with a net margin of -0.5%. It held $9.87M in total assets against $4.69M in total liabilities.
Key ratios (FY2026)
-0.6%
Operating margin
-0.5%
Net margin
-0.4%
Return on equity
-22.7%
Revenue growth (YoY)
| Metric (FY) | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $4.81M | $6.22M | $6.02M | — |
| Cost of Revenue | $35.2K | $15.5K | $11.3K | — |
| Operating Income | -$29.2K | $1.39M | $1.01M | — |
| Net Income | -$22.6K | $1.20M | $777.8K | — |
| EPS (Diluted) | $0.00 | $0.08 | $0.05 | — |
| Total Assets | $9.87M | $5.36M | — | — |
| Total Liabilities | $4.69M | $5.31M | — | — |
| Shareholders' Equity | $5.18M | $49.2K | -$1.15M | -$1.27M |
| Cash & Equivalents | $4.70M | $816.8K | — | — |
| Operating Cash Flow | -$1.22M | $425.9K | $295.4K | — |
| Capital Expenditures | $339.6K | $287.5K | $210.6K | — |
| Shares Outstanding | 16.15M | 15.34M | 15.34M | — |